Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prediction of antibody persistency from antibody titres to natalizumab.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
Dysphagia in stroke, neurodegenerative disease, and advanced dementia.
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
"Disease modifying nutricals" for multiple sclerosis.
A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Communication with patients suffering from serious physical illness.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
The high cost of spasticity in multiple sclerosis to individuals and society.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica.
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
Patient and equipment profile for wheelchair seating clinic provision.
Acute Disseminated Encephalomyelitis Associated With Acute Toxoplasma gondii Infection.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »